MedTrace Logo

A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough.

NCT03415269 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2019-06-20

No results posted yet for this study

Summary

To assess the effect of a single doses of 20 mg ambroxol hydrochloride on cough reflex sensitivity to citric acid, capsaicin, adenosine triphosphate (ATP) and distilled water in patients with acute cough related to upper respiratory tract infection

Conditions

Interventions

DRUG

Ambroxol Hydrochloride

single lozenge of 20mg ambroxol

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Hull University Teaching Hospitals NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Alyn H Morice · Hull University Teaching Hospitals NHS Trust

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2018-04-19
Completion
2018-04-19

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03415269 on ClinicalTrials.gov